Clinical Trial Update: A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating multiple oral doses of linaclotide in children aged 7-17 with irritable bowel syndrome with constipation; study terminated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Linaclotide (linaclotide)

Snippet

Sponsor: Forest Laboratories | Conditions: Irritable Bowel Syndrome With Constipation | Phase 2 | Status: TERMINATED | Results posted: 2020-12-28